Apogee Therapeutics Inc (APGE)
50.40
-3.35
(-6.23%)
USD |
NASDAQ |
May 20, 10:17
Apogee Therapeutics Shareholders Equity (Quarterly): 501.28M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 501.28M |
| June 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
501.28M
Maximum
Sep 2023
125.32M
Average
--
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| DaVita Inc | 926.00M |
| Cardio Diagnostics Holdings Inc | 2.958M |
| Protagenic Therapeutics Inc | 3.668M |
| Macrogenics Inc | 106.15M |
| Marinus Pharmaceuticals Inc | -16.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 426.42M |
| Total Liabilities (Quarterly) | 17.18M |